<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Biotechnology</title>
    <subTitle>the science, the products, the government, the business</subTitle>
  </titleInfo>
  <name type="personal">
    <namePart>Evens, Ronald P.</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
    <role>
      <roleTerm type="text">author.</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">flu</placeTerm>
    </place>
    <dateIssued encoding="marc">2020</dateIssued>
    <edition>First edition.</edition>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">print</form>
    <extent>xix, 182p. : ill ; 25 cm</extent>
  </physicalDescription>
  <abstract>"The over-riding premise for biotechnology in this book is bringing novel products to market to substantially advance patient care and disease mitigation. Biotechnology, over its relatively brief existence of 40 years, has experienced a mercurial growth. The vast educational need for biotechnology information in this rapidly burgeoning field is a basic rationale here. However a more prominent underpinning is that, bringing biotech products to market for patient care involves success in the following four areas of engagement simultaneously - scientific advances for healthcare technologies, novel and varied products for untreated diseases, regulatory authorities, and biotech companies. Features comprehensive coverage of biotechnology science topics used in development and manufacturing, addresses all the scientific technologies within biotechnology responsible for products on the market and the pipeline, presents business issues such as marketing and sales of the products, as well as companies engaged, and how biotech business has evolved"--</abstract>
  <note type="statement of responsibility">by Ronald P. Evens.</note>
  <note>Includes bibliographical references and index.</note>
  <subject authority="lcsh">
    <topic>Pharmaceutical biotechnology</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Pharmaceutical biotechnology industry</topic>
  </subject>
  <classification authority="lcc">RS380 .E94 2020</classification>
  <classification authority="ddc" edition="23">615.19 EVE</classification>
  <relatedItem type="series">
    <titleInfo>
      <title>Drugs and the pharmaceutical sciences</title>
    </titleInfo>
  </relatedItem>
  <identifier type="isbn">9780367024673</identifier>
  <identifier type="isbn" invalid="yes"/>
  <identifier type="lccn">2020009451</identifier>
  <recordInfo>
    <recordContentSource authority="marcorg">KABLIB</recordContentSource>
    <recordCreationDate encoding="marc">200423</recordCreationDate>
    <recordChangeDate encoding="iso8601">20260227104955.0</recordChangeDate>
    <recordIdentifier source="OSt">21509697</recordIdentifier>
    <languageOfCataloging>
      <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
    </languageOfCataloging>
  </recordInfo>
</mods>
